Provided by Tiger Trade Technology Pte. Ltd.

GENSCRIPT BIO

36.380
+2.5007.38%
Volume:34.00M
Turnover:1.23B
Market Cap:79.96B
PE:-18.88
High:37.060
Open:34.000
Low:34.000
Close:33.880
52wk High:37.060
52wk Low:10.360
Shares:2.20B
HK Float Shares:2.20B
Volume Ratio:1.27
T/O Rate:1.55%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.927
ROE:-15.33%
ROA:1.54%
PB:2.62
PE(LYR):-18.88
PS:12.07

Loading ...

Movement Alert|GenScript Biotech Falls 5.05% in Regular Trading, CXO Sector Under Sustained Pressure Amid US Investment Restriction Concerns

Market Focus
·
Jun 09

Movement Alert|GenScript Biotech Intraday Decline 7.04%, CXO Sector Sells Off Amid Broader Market Weakness

Market Focus
·
Jun 08

Genscript Biotech adopts fifth-amended Articles; authorises 5 billion shares and formalises hybrid meeting, treasury share and electronic securities rules

Bulletin Express
·
Jun 05

Genscript Biotech AGM Endorses 2025 Financials, Board Re-election and Expanded Share Mandates

Bulletin Express
·
Jun 05

GenScript Biotech held annual general meeting, shareholders adopted amended articles of association

Reuters
·
Jun 05

GENSCRIPT BIO Awards 14.74 Million Restricted Share Units in Total

Stock News
·
Jun 04

GENSCRIPT BIO grants 14.74 million RSUs, equal to 0.67% of share capital

Bulletin Express
·
Jun 04

GenScript Biotech grants 14,736,658 RSUs under 2021 share award scheme

Reuters
·
Jun 04

Hong Kong Market Closes Lower, Optical Communication Stocks Defy Trend, Energy Shares Rally in Afternoon Session

Stock News
·
Jun 03

Genscript Associate to Present Data for Lymphoma Drug at European Conference; Shares Surge 11%

MT Newswires Live
·
Jun 03

Market Chatter: Genscript Biotech Defends Operations Amid Renewed U.S. Lawmaker Scrutiny

MT Newswires Live
·
Jun 03

BUZZ-Genscript hits 4-week high on associate's promising blood cancer cell therapy

Reuters
·
Jun 03

Movement Alert|GenScript Biotech Rises 23.48% in Regular Trading, Legend Biotech In Vivo CAR-T Clinical Data Shows Positive Signals

Market Focus
·
Jun 03

Stock Track | GENSCRIPT BIO Soars 14.99% Intraday on Positive Clinical Data from Associate Legend Biotech

Stock Track
·
Jun 03

Genscript Biotech Soars on Positive Clinical Data from Affiliate Legend Biotech

Stock News
·
Jun 03

Key Developments for Hong Kong Stocks: Gold Surpasses U.S. Bonds as Top Reserve Asset; NVIDIA's Spectrum-X Ethernet Silicon Photonics Tech Enters Full Production

Stock News
·
Jun 03

GenScript Biotech’s Associate Legend Biotech Schedules Late-Breaking Oral at EHA 2026 to Reveal Initial Phase 1 In Vivo CAR-T Data for LB2501 in R/R B-NHL

Bulletin Express
·
Jun 02

GenScript says Legend to present Phase 1 in vivo CAR-T LB2501 data at EHA congress

Reuters
·
Jun 02

GENSCRIPT BIO discloses Legend Biotech’s first-in-human LB2102 CAR-T results and new CARVYKTI® data presented at ASCO 2026

Bulletin Express
·
Jun 01

Genscript Biotech Reports LB2102 Solid Tumor Initial Human Study Results and CARVYKTI® Latest Data in Myeloma at 2026 ASCO

Stock News
·
Jun 01